NeuroOne Medical Technologies press release (NMTC): Q2 GAAP EPS of -$0.25 misses by $0.02. – Product revenue of $2.4M (+71.4% Y/Y) misses by $0.18M. – As of March 31, 2026, the Company had cash and cash equivalents of $2.8 million, compared to $6.6 million as of September
Neuroone Medical Technologies GAAP EPS of -$0.25 Misses by $0.02, Revenue of $2.4M Misses by $0.18m
NeuroOne Medical Technologies press release (NMTC): Q2 GAAP EPS of -$0.25 misses by $0.02. - Product revenue of $2.4M (+71.4% Y/Y) misses by $0.18M. - As of March 31, 2026, the Company had cash and cash equivalents of $2.8 million, compared to $6.6 million as of September